 Prognostic significance anticentromere antibodies anti-topoisomerase antibodies Raynaud disease prospective study Seventy-seven patients Raynaud disease mean years years relationship autoantibodies long-term clinical outcome Anticentromere antibodies ACA indirect immunofluorescence HeLa cell chromosome extracts Antibodies anti-topo immunodiffusion immunoblotting Antibodies major centromeric protein CENP-B anti-topo enzyme-linked immunosorbent assay ELISA patients telangiectasias skin tightening connective tissue disease scleroderma presence ACA start study development telangiectasias initial band immunoblot conjunction positive anti-topo ELISA result development tight skin band negative anti-topo ELISA result subsequent development connective tissue disease scleroderma Patients ACA positive band immunoblot positive ELISA results anti-topo anti-CENP-B likely signs connective tissue disease end study presence autoantibodies sensitive specific findings nailfold capillaroscopy sensitivity specificity subsequent clinical progression findings assays anti-topo ACA findings nailfold capillaroscopy useful prognostic information Raynaud disease